Prelude Therapeutics Inc SC 13G and SC 13G/A reports

Location
175 Innovation Boulevard, Wilmington, Delaware
State of incorporation
Delaware
Fiscal year end
December 31
Data updated at
6/19/2024, 01:22 AM
Form type Sec Links Description Filing date Reporting date
SC 13G/A Report EXIT FILING Feb 13, 2024
SC 13G/A Report Feb 12, 2024
SC 13G/A Report SC 13G/A Feb 12, 2024
SC 13G/A Report Jan 10, 2024
SC 13G Report SCHEDULE 13G Nov 13, 2023
SC 13G Report Feb 13, 2023
SC 13G/A Report Feb 10, 2023
SC 13G/A Report SC 13G/A Feb 10, 2023
SC 13G/A Report Feb 9, 2023
SC 13G/A Report Feb 9, 2022
SC 13G/A Report SC 13G/A Feb 4, 2022
SC 13G Report SC 13G Feb 11, 2021
SC 13G/A Report Feb 10, 2021
SC 13G Report Feb 8, 2021